Search results
Showing 16 to 24 of 24 results for extracorporeal membrane oxygenation
NICE has developed a medtech innovation briefing (MIB) on CytoSorb therapy for sepsis .
NPi-200 for pupillary light reflex in critical care patients (MIB235)
NICE has developed a medtech innovation briefing (MIB) on NPi-200 for pupillary light reflex in critical care patients .
This guidance has been updated and replaced by NICE HealthTech guidance 260.
Extra corporeal membrane oxygenation for acute heart failure in children
Discontinued Reference number: GID-IP1153
Extracorporeal membrane oxygenation (ECMO) in postneonatal children (IPG38)
We have moved interventional procedures guidance 38 to become HealthTech guidance 17. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults (IPG482)
This guidance has been updated and replaced by NICE interventional procedures guidance 807, 808 and 810.
Extracorporeal membrane oxygenation for severe acute respiratory failure in adults (IPG391)
Interventional procedures, IPG391 - Issued: April 2011 --> We have moved interventional procedures guidance 391 to become HealthTech guidance 260. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions (MIB89)
NICE has developed a medtech innovation briefing (MIB) on Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions .
This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.